share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股sec公告 ·  07/10 13:04
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 07/10/2024, with an aggregate market value of $374,000. These shares were originally acquired on 09/01/2016 as founders shares and were part of Gibson's compensation from the issuer. This planned sale follows a recent history of transactions where a total of 200,000 shares were sold over the past three months, generating gross proceeds of $1,681,000.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 07/10/2024, with an aggregate market value of $374,000. These shares were originally acquired on 09/01/2016 as founders shares and were part of Gibson's compensation from the issuer. This planned sale follows a recent history of transactions where a total of 200,000 shares were sold over the past three months, generating gross proceeds of $1,681,000.
Recursion Pharmaceuticals, Inc.官員和董事Christopher Gibson計劃在07/10/2024出售50,000股A類股票,市場總價值爲$374,000。這些股票最初是在2016年9月1日以創始人的身份獲得的,並且是Gibson從發行人獲得的報酬的一部分。此次計劃出售是在過去三個月內進行的總計200,000股股票交易的基礎上成立的,合計獲得1,681,000美元的總收入。
Recursion Pharmaceuticals, Inc.官員和董事Christopher Gibson計劃在07/10/2024出售50,000股A類股票,市場總價值爲$374,000。這些股票最初是在2016年9月1日以創始人的身份獲得的,並且是Gibson從發行人獲得的報酬的一部分。此次計劃出售是在過去三個月內進行的總計200,000股股票交易的基礎上成立的,合計獲得1,681,000美元的總收入。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息